Correlation Between CanSino Biologics and Charles Schwab

Can any of the company-specific risk be diversified away by investing in both CanSino Biologics and Charles Schwab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CanSino Biologics and Charles Schwab into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CanSino Biologics and The Charles Schwab, you can compare the effects of market volatilities on CanSino Biologics and Charles Schwab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CanSino Biologics with a short position of Charles Schwab. Check out your portfolio center. Please also check ongoing floating volatility patterns of CanSino Biologics and Charles Schwab.

Diversification Opportunities for CanSino Biologics and Charles Schwab

0.6

Correlation Coefficient

CanSino Biologics  Charles Schwab

Poor diversification

The 3 months correlation between CanSino and Charles is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding CanSino Biologics and The Charles Schwab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charles Schwab and CanSino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CanSino Biologics are associated (or correlated) with Charles Schwab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charles Schwab has no effect on the direction of CanSino Biologics i.e., CanSino Biologics and Charles Schwab go up and down completely randomly.

Pair Corralation between CanSino Biologics and Charles Schwab

Assuming the 90 days trading horizon CanSino Biologics is expected to generate 1.89 times more return on investment than Charles Schwab. However, CanSino Biologics is 1.89 times more volatile than The Charles Schwab. It trades about 0.13 of its potential returns per unit of risk. The Charles Schwab is currently generating about 0.03 per unit of risk. If you would invest  220.00  in CanSino Biologics on October 4, 2024 and sell it today you would earn a total of  172.00  from holding CanSino Biologics or generate 78.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CanSino Biologics  vs.  The Charles Schwab

CanSino Biologics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Charles Schwab

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in The Charles Schwab are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Charles Schwab reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CanSino Biologics and Charles Schwab

The main advantage of trading using opposite CanSino Biologics and Charles Schwab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CanSino Biologics position performs unexpectedly, Charles Schwab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles Schwab will offset losses from the drop in Charles Schwab's long position.

The idea behind CanSino Biologics and The Charles Schwab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.